BIOCENTURY Danielle Golovin, Senior Biopharma Analyst |
Chemical & Engineering News |
R&D for long COVID is collapsing
The National News |
Big Pharma treating mpox as African problem puts global population at risk
PharmaVoice |
Why pharma isn’t done tackling migraines
Inside Health Policy |
Executive Order Could Lead To Big Subsidies For Domestic Biopharmaceutical Manufacturing
Nature Biotechnology |
Monkeypox response relies on three vaccine suppliers
The Frederick News-Post |
Tonix Pharmaceuticals develops monkeypox vaccine for future by looking at past
BioProcess International |
Tonix looks to live virus vaccines to prevent the spread of monkeypox
New Bedford Guide |
Tonix Pharmaceuticals facility officially opens in the New Bedford Business Park
BioCentury |
Poxvirus agents, by the mechanisms
The New York Times |